Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
0.486
-0.064 (-11.64%)
At close: Mar 9, 2026, 4:00 PM EDT
0.519
+0.033 (6.87%)
After-hours: Mar 9, 2026, 7:36 PM EDT
Harvard Bioscience Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 21 | 92 | 228 | 115 | 288 | 167 | |
| Market Cap Growth | -50.30% | -59.70% | 97.92% | -59.89% | 72.07% | 44.02% | |
| Enterprise Value | 57 | 133 | 268 | 167 | 336 | 218 | |
| Last Close Price | 0.49 | 2.11 | 5.35 | 2.77 | 7.05 | 4.29 | |
| Forward PE | 5.40 | 17.58 | 23.26 | 17.87 | 22.03 | 16.19 | |
| PS Ratio | 0.25 | 0.98 | 2.04 | 1.02 | 2.42 | 1.64 | |
| PB Ratio | 1.54 | 1.45 | 3.13 | 1.60 | 3.45 | 2.18 | |
| P/FCF Ratio | 2.89 | - | 18.66 | - | 4294.24 | 20.44 | |
| P/OCF Ratio | 2.51 | 63.91 | 16.28 | 100.17 | 227.98 | 17.92 | |
| PEG Ratio | - | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | |
| EV/Sales Ratio | 0.66 | 1.42 | 2.39 | 1.48 | 2.83 | 2.14 | |
| EV/EBITDA Ratio | 11.52 | 54.64 | 28.27 | 70.15 | 29.73 | 22.08 | |
| EV/EBIT Ratio | - | - | 107.55 | - | 91.12 | 96.86 | |
| EV/FCF Ratio | 7.72 | - | 21.92 | - | 5018.20 | 26.69 | |
| Debt / Equity Ratio | 3.04 | 0.70 | 0.59 | 0.75 | 0.68 | 0.75 | |
| Debt / EBITDA Ratio | 5.87 | 9.65 | 3.70 | 12.09 | 4.24 | 4.79 | |
| Debt / FCF Ratio | 5.75 | - | 3.51 | - | 850.15 | 7.04 | |
| Net Debt / Equity Ratio | 2.56 | 0.64 | 0.48 | 0.69 | 0.59 | 0.64 | |
| Net Debt / EBITDA Ratio | 7.21 | 16.55 | 3.71 | 20.87 | 4.34 | 4.99 | |
| Net Debt / FCF Ratio | 4.83 | -33.54 | 2.88 | -113.55 | 733.42 | 6.03 | |
| Asset Turnover | 0.84 | 0.71 | 0.79 | 0.74 | 0.75 | 0.64 | |
| Inventory Turnover | 1.58 | 1.64 | 1.79 | 1.89 | 2.06 | 1.99 | |
| Quick Ratio | 0.35 | 0.35 | 0.77 | 0.91 | 1.17 | 1.24 | |
| Current Ratio | 0.81 | 0.82 | 1.85 | 2.20 | 2.43 | 2.46 | |
| Return on Equity (ROE) | -135.62% | -18.19% | -4.70% | -12.23% | -0.36% | -9.86% | |
| Return on Assets (ROA) | -0.82% | -2.23% | 1.10% | -2.11% | 1.45% | 0.88% | |
| Return on Invested Capital (ROIC) | -2.69% | -4.38% | 2.14% | -4.08% | 2.85% | 1.70% | |
| Return on Capital Employed (ROCE) | -5.80% | -6.60% | 2.30% | -4.30% | 2.70% | 1.70% | |
| Earnings Yield | -250.73% | -13.48% | -1.49% | -8.25% | -0.10% | -4.67% | |
| FCF Yield | 34.65% | -1.31% | 5.36% | -0.38% | 0.02% | 4.89% | |
| Buyback Yield / Dilution | -2.01% | -2.64% | -2.43% | -2.65% | -4.41% | -2.19% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.